China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on Active Monitoring and Intelligent Management of the Whole Course of Targeted Therapy for Common Malignant Tumors Based on Patient-Reported Outcomes'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136675
Registration Time: 2026/11/13
Type: Observational study
Primary Sponsor: Beijing Chest Hospital, Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=353275
Published by HT Digital Content Services with permission from Health Daily Digest....